Endothelial progenitor cells in pulmonary hypertension – dawn of cell‐based therapy?

@article{Toshner2010EndothelialPC,
  title={Endothelial progenitor cells in pulmonary hypertension – dawn of cell‐based therapy?},
  author={M. Toshner and N. W Morrell},
  journal={International Journal of Clinical Practice},
  year={2010},
  volume={64}
}
  • M. Toshner, N. W Morrell
  • Published 2010
  • Medicine
  • International Journal of Clinical Practice
  • There is mounting interest in the concept of endothelial progenitor cell (EPC) therapy for the treatment of pulmonary arterial hypertension (PAH). Recent successful pilot studies in idiopathic PAH have raised questions about the contribution of progenitor cells circulating in the peripheral blood to pulmonary vascular homeostasis and to the process of vascular remodelling. This review will summarise the work performed to date in animal and human therapeutic trials and clarify what is known… CONTINUE READING

    Topics from this paper.

    Estrogen metabolism in pulmonary arterial hypertension
    Programmatic change: lung disease research in the era of induced pluripotency.
    • 5
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 42 REFERENCES